D.J. St. Germain’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.3M | Sell |
68,593
-37
| -0.1% | -$7.96K | 0.62% | 54 |
|
|
2026
Q1 | $14.9M | Sell |
68,630
-183
| -0.3% | -$40.6K | 0.59% | 57 |
|
|
2025
Q4 | $15.7M | Buy |
68,813
+358
| +0.5% | +$81.6K | 0.61% | 53 |
|
|
2025
Q3 | $15.9M | Buy |
68,455
+436
| +0.6% | +$88.8K | 0.63% | 55 |
|
|
2025
Q2 | $12.6M | Buy |
68,019
+1,315
| +2% | +$244K | 0.54% | 59 |
|
|
2025
Q1 | $14M | Sell |
66,704
-1,404
| -2% | -$273K | 0.66% | 49 |
|
|
2024
Q4 | $12.1M | Buy |
68,108
+548
| +0.8% | +$101K | 0.55% | 57 |
|
|
2024
Q3 | $13.3M | Buy |
67,560
+116
| +0.2% | +$21.6K | 0.61% | 56 |
|
|
2024
Q2 | $11.6M | Sell |
67,444
-118
| -0.2% | -$19.5K | 0.56% | 58 |
|
|
2024
Q1 | $12.3M | Buy |
67,562
+340
| +0.5% | +$58.6K | 0.6% | 55 |
|
|
2023
Q4 | $10.4M | Buy |
67,222
+1,841
| +3% | +$268K | 0.54% | 61 |
|
|
2023
Q3 | $9.75M | Sell |
65,381
-5,632
| -8% | -$827K | 0.55% | 59 |
|
|
2023
Q2 | $9.57M | Buy |
+71,013
| New | +$10.4M | 0.51% | 61 |
|
|
2022
Q4 | $9.55M | Buy |
130,708
+59,077
| +82% | +$9.06M | 3.21% | 8 |
|
|
2022
Q3 | $11M | Hold |
71,631
| – | – | 0.72% | 46 |
|
|
2022
Q2 | $11M | Buy |
71,631
+296
| +0.4% | +$45.2K | 0.72% | 46 |
|
|
2022
Q1 | $11.6M | Sell |
71,335
-9,529
| -12% | -$1.38M | 0.65% | 54 |
|
|
2021
Q4 | $10.9M | Buy |
80,864
+4,590
| +6% | +$542K | 0.6% | 52 |
|
|
2021
Q3 | $8.23M | Sell |
76,274
-1,631
| -2% | -$186K | 0.51% | 60 |
|
|
2021
Q2 | $8.78M | Buy |
77,905
+125
| +0.2% | +$14.1K | 0.55% | 54 |
|
|
2021
Q1 | $8.42M | Buy |
77,780
+6,420
| +9% | +$687K | 0.57% | 52 |
|
|
2020
Q4 | $7.65M | Buy |
71,360
+791
| +1% | +$76K | 0.55% | 52 |
|
|
2020
Q3 | $6.18M | Sell |
70,569
-786
| -1% | -$74K | 0.5% | 56 |
|
|
2020
Q2 | $7.01M | Buy |
71,355
+2
| +0% | +$176 | 0.61% | 49 |
|
|
2020
Q1 | $5.44M | Sell |
71,353
-1,658
| -2% | -$141K | 0.53% | 56 |
|
|
2019
Q4 | $6.46M | Buy |
73,011
+60,654
| +491% | +$5.04M | 0.54% | 53 |
|
|
2019
Q3 | $936K | Sell |
12,357
-350
| -3% | -$24K | 0.1% | 94 |
|
|
2019
Q2 | $924K | Sell |
12,707
-1,205
| -9% | -$94.7K | 0.1% | 91 |
|
|
2019
Q1 | $1.12M | Sell |
13,912
-65
| -0.5% | -$5.32K | 0.12% | 86 |
|
|
2018
Q4 | $1.29M | Buy |
13,977
+1,245
| +10% | +$109K | 0.15% | 83 |
|
|
2018
Q3 | $1.2M | Buy |
12,732
+548
| +4% | +$52K | 0.13% | 79 |
|
|
2018
Q2 | $1.13M | Buy |
12,184
+1,712
| +16% | +$167K | 0.13% | 78 |
|
|
2018
Q1 | $991K | Buy |
10,472
+4,877
| +87% | +$536K | 0.13% | 78 |
|
|
2017
Q4 | $541K | Buy |
5,595
+2,118
| +61% | +$200K | 0.06% | 96 |
|
|
2017
Q3 | $309K | Sell |
3,477
-240
| -6% | -$18.3K | 0.04% | 120 |
|
|
2017
Q2 | $270K | Buy |
+3,717
| New | +$250K | 0.04% | 126 |
|
Other funds holding ABBV
D.J. St. Germain's ABBV Position: Q2 2026 in Review
D.J. St. Germain reduced its AbbVie (ABBV) stake by 0.05% in Q2 2026, selling an estimated $7.96K and leaving 68,593 shares worth $17.3M. The position accounts for 0.62% of the portfolio, ranked #54.
D.J. St. Germain first reported a position in ABBV in Q2 2017 and has held it in 36 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- D.J. St. Germain held 68,593 shares of AbbVie worth $17.3M as of Q2 2026.
- D.J. St. Germain sold 37 AbbVie shares in Q2 2026, an estimated $7.96K.
- AbbVie made up 0.62% of D.J. St. Germain's portfolio in Q2 2026, its #54 holding.
- D.J. St. Germain first reported a position in AbbVie in Q2 2017 and has held it in 36 quarters since.
- 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.